Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBPP) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Regen BioPharma (RGBPP) over the last 12 years, with Q3 2025 value amounting to 1.43.

  • Regen BioPharma's Interest Coverage Ratio rose 6637.24% to 1.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 2.14, marking a year-over-year increase of 6286.3%. This contributed to the annual value of 2.14 for FY2025, which is 6286.27% up from last year.
  • As of Q3 2025, Regen BioPharma's Interest Coverage Ratio stood at 1.43, which was up 6637.24% from 1.65 recorded in Q2 2025.
  • In the past 5 years, Regen BioPharma's Interest Coverage Ratio ranged from a high of 1.07 in Q3 2021 and a low of 574.2 during Q2 2021
  • Over the past 5 years, Regen BioPharma's median Interest Coverage Ratio value was 4.26 (recorded in 2024), while the average stood at 44.08.
  • As far as peak fluctuations go, Regen BioPharma's Interest Coverage Ratio tumbled by 28581681.22% in 2021, and later skyrocketed by 9966.25% in 2022.
  • Over the past 5 years, Regen BioPharma's Interest Coverage Ratio (Quarter) stood at 3.04 in 2021, then tumbled by 779.08% to 26.72 in 2022, then soared by 74.16% to 6.9 in 2023, then surged by 64.93% to 2.42 in 2024, then skyrocketed by 40.88% to 1.43 in 2025.
  • Its Interest Coverage Ratio stands at 1.43 for Q3 2025, versus 1.65 for Q2 2025 and 5.08 for Q1 2025.